Time To Rake In Healthy Returns From Sunrun Inc. (RUN)

Sunrun Inc. (RUN) shares saw a recent bid of $7.27 and 1.9M shares have exchanged hands in the recent trading session, yielding a 9.32% gain over the past week. The stock price increased 2.39% or $-0.17 versus $7.10 at the end of the prior session. This change led market cap to move at $751.57M, putting the price -0.95% below the 52-week high and 75.18% above the 52-week low. The company’s stock has a normal trading capacity of 1.17M shares while the relative volume is 1.62.

To stay one step ahead we extended our research by comparing different price targets. The stock notched a 12-month high of $9.21 while $12.00 target is by far the most aggressive out of analysts who are currently evaluating the company, $2.79 higher than the next highest 52-week price estimate. The lowest 12-month price target for the shares is $6.00, which would be decrease of about -17% of its current value. The mean target of $10.00 should be compared with the price when the stock was languishing around $4.15 a share. And it remains to be seen which target price RUN can achieve without sacrificing much as the company is holding a 28.67% gain for the past twelve months.

By historical standards, Sunrun Inc. remains a cheap stock. The company’s current price-earnings ratio amounts to 8.20 times earnings, below the average P/E ratio of 15.10 times earnings. For now, Sunrun Inc. is the toast of Wall Street as its ABR stands at 2.00 with 3 out of 8 analysts rating the stock a buy. Over the short term, some market observers may have noticed that Sunrun Inc. has a 21.27% short float with 15 days to cover. It becomes significant when you consider how many shares are shorted versus the average daily volume, means how many days to cover those short shares at that volume. Sunrun Inc. has far performed well this year, with the share price up 36.91% since January. Over the past 2 quarters, the stock is up 33.64%, compared with a gain of nearly 39.27% for 3 months and about 44.25% for the past 30 days.

Last time, the company failed Wall Street by reporting EPS of $0.12, smashing the consensus of $0.14 per share. Revenue for the quarter also did not kill consensus, coming in at $104.12M, compared to the consensus of 119.35M. Nonetheless, from here on out, earnings per share forecasts for the current quarter are $0.34. The company is expected to report EPS as high as $0.74 and as low as $0.06 per share. Similarly, full-year EPS forecasts have ranged between $0.33 and $2.25. The mean EPS estimate is $1.14. On the other side, sales forecasts for the current quarter are $142.74M. The stock is expected to report revenue as high as $150.6M and as low as $132.2M per share. Similarly, full-year sales forecasts have ranged between $528M and $717.96M. The mean revenue estimate is $575.05M.

Over the last 5 years, Analysts are expecting EPS growth rates to be at 190.60% this quarter and EPS estimate for next year reflect 17.59% growth rate.

Sell-side analysts also have something to say about this company. UBS raised its rating on Sunrun Inc. to Buy on 22/03/2017 in a reversal from its prior Neutral rating. Barclays raised its rating on Sunrun Inc. to Overweight on 22/11/2016 in a reversal from its prior Equal Weight rating. JMP Securities had a markedly different take on 10/11/2016, proposing that Sunrun Inc. is now considered Mkt Perform versus prior Mkt Outperform rating. BofA/Merrill had a markedly different take on 09/11/2016, proposing that Sunrun Inc. is now considered Neutral versus prior Buy rating.

Why These Stocks Remain in Focus? – Sunrun Inc. (RUN), Celldex Therapeutics, Inc. (CLDX)

Sunrun Inc. (NASDAQ:RUN) was up 1.50% at $6.75 on Saturday, in a 52-week range of $4.15 to $7.34 and with a consensus analyst target price of $10.06. As for the mean price target, it implies upside of 51.28% from the $6.65 prior closing price. Sunrun Inc. has a 697.82M market cap and its past year revenues were 459.30M. Going from the most negative analyst price target to above consensus is one thing. Now Sunrun Inc.’s current price is $5.25 shy of the official highest sell-side analyst price target on Wall Street.

Sunrun Inc. (NASDAQ:RUN) has risen 27.12% since January and is up 17.60% for the past week. The share price of RUN has risen by over 22.06% in the last six months. This increase is typical for the uptrend and shows the considerable optimism among investors.

A look at some of the inputs to technical analysis model shows how Sunrun Inc. current price compares to its recent moving averages. Sunrun Inc. is currently trading 23.96% above its 20-day and 23.04% versus the 200-day simple moving averages while 29.33% compared with its 50-day simple moving average. Additionally, Sunrun Inc. (RUN) stock price has gone up by 37.20% over the last 20 trading days, and its price is -8.04% below the 52-week high.

For a total return analysis, there is the -14.40% return on equity and the 14.00% return on assets to consider. According to the past 12 months report, the income was almost $91.30M and sales remained $459.30M. Its price to sales ratio of 1.55 ranks lower than the industry’s 2.15. Its price/book multiple of 1.02 compared with the 3.91 while its free cash flow yield should be matched with that of its industry’s 12.07.

The Average True Range indicator applied to a daily chart of Apple has a current ATR reading of 0.25. This gives traders an indication of how much volatility or movement they can expect each day. Average True Range looks at the distance the price is traveling each day and plots it on a graph. The ATR reading can then be used by traders to determine when markets are most likely to range, when there is a high interest in a trend, or when extreme levels are being reached indicating a reversal.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares were last seen up 1.55% at $2.62, which is 151.94% higher than the previous trading session. The 52-week range is $2.20 to $5.02 and the consensus target price is $6.50. The company has a market cap of $322.73M and its 12 month revenue was almost $7.00M. The stock has been downbeat for quite some time as is down -15.48% for the last 20 trading days, and now the firm’s performance is turning out to be bullish with a 12.93% gain for the week. It has fall by over -42.67% in the last twelve months.

Going from the most bullish analyst price target to below consensus is one thing. Now Celldex Therapeutics, Inc. $6.50 target price is just $2.5 shy of the official lowest sell-side analyst price target on Wall Street. It looks like analysts are feeling bearish about the stock with overall sell-side analysts calling it a Buy. Their price objective ranges between $3.50 and $9.00.

For a profitability analysis, According to the past 5 years report, the company on average reported -2.20% year-over-year EPS growth and sales growth was recorded at -6.00%. Its forward price to earnings ratio ranks lower than the industry’s 239.63. Its quick ratio was 6.40 while current ratio was noted as 6.40 in the most recent quarter.

Sunrun Inc. (RUN) Share Price Could Be Rising After 25.24% gain In 2017

Sunrun Inc. (RUN) shares saw a recent bid of $6.65 and 2.01M shares have exchanged hands in the recent trading session, yielding a 20.47% gain over the past week. The stock price increased 1.99% or $-0.13 versus $6.52 at the end of the prior session. This change led market cap to move at $674.38M, putting the price -9.40% below the 52-week high and 60.24% above the 52-week low. The company’s stock has a normal trading capacity of 1.08M shares while the relative volume is 1.87.

To stay one step ahead we extended our research by comparing different price targets. The stock notched a 12-month high of $9.21 while $12.00 target is by far the most aggressive out of analysts who are currently evaluating the company, $2.79 higher than the next highest 52-week price estimate. The lowest 12-month price target for the shares is $6.00, which would be decrease of about -10% of its current value. The mean target of $10.00 should be compared with the price when the stock was languishing around $4.15 a share. And it remains to be seen which target price RUN can achieve without sacrificing much as the company is holding a 12.71% gain for the past twelve months.

By historical standards, Sunrun Inc. remains a cheap stock. The company’s current price-earnings ratio amounts to 7.53 times earnings, below the average P/E ratio of 15.48 times earnings. For now, Sunrun Inc. is the toast of Wall Street as its ABR stands at 2.00 with 3 out of 8 analysts rating the stock a buy. Over the short term, some market observers may have noticed that Sunrun Inc. has a 21.27% short float with 15 days to cover. It becomes significant when you consider how many shares are shorted versus the average daily volume, means how many days to cover those short shares at that volume. Sunrun Inc. has far performed well this year, with the share price up 25.24% since January. Over the past 2 quarters, the stock is up 19.82%, compared with a gain of nearly 37.40% for 3 months and about 35.99% for the past 30 days.

Last time, the company failed Wall Street by reporting EPS of $0.12, smashing the consensus of $0.14 per share. Revenue for the quarter also did not kill consensus, coming in at $104.12M, compared to the consensus of 119.35M. Nonetheless, from here on out, earnings per share forecasts for the current quarter are $0.34. The company is expected to report EPS as high as $0.74 and as low as $0.06 per share. Similarly, full-year EPS forecasts have ranged between $0.33 and $2.25. The mean EPS estimate is $1.14. On the other side, sales forecasts for the current quarter are $142.74M. The stock is expected to report revenue as high as $150.6M and as low as $132.2M per share. Similarly, full-year sales forecasts have ranged between $528M and $717.96M. The mean revenue estimate is $575.05M.

Over the last 5 years, Analysts are expecting EPS growth rates to be at 190.60% this quarter and EPS estimate for next year reflect 19.20% growth rate.

Sell-side analysts also have something to say about this company. UBS raised its rating on Sunrun Inc. to Buy on 22/03/2017 in a reversal from its prior Neutral rating. Barclays raised its rating on Sunrun Inc. to Overweight on 22/11/2016 in a reversal from its prior Equal Weight rating. JMP Securities had a markedly different take on 10/11/2016, proposing that Sunrun Inc. is now considered Mkt Perform versus prior Mkt Outperform rating. BofA/Merrill had a markedly different take on 09/11/2016, proposing that Sunrun Inc. is now considered Neutral versus prior Buy rating.

Official Price Target Objectives For Allergan plc (AGN), Sunrun Inc. (RUN)

Allergan plc (NYSE:AGN) was up 2.41% at $244.39 on Tuesday, in a 52-week range of $184.50 to $261.27 and with a consensus analyst target price of $271.72. As for the mean price target, it implies upside of 13.87% from the $238.63 prior closing price. Allergan plc has a 81.83B market cap and its past year revenues were 14.74B. Going from the most negative analyst price target to above consensus is one thing. Now Allergan plc’s current price is $155.61 shy of the official highest sell-side analyst price target on Wall Street.

Allergan plc (NYSE:AGN) has risen 16.37% since January and is up 4.87% for the past week. The share price of AGN has increased by over 26.92% in the last six months. This increase is typical for the uptrend and shows the considerable optimism among investors.

A look at some of the inputs to technical analysis model shows how Allergan plc current price compares to its recent moving averages. Allergan plc is currently trading 6.69% above its 20-day and 8.33% versus the 200-day simple moving averages while 4.92% compared with its 50-day simple moving average. Additionally, Allergan plc (AGN) stock price has gone up by 11.33% over the last 20 trading days, and its price is -6.46% below the 52-week high.

For a total return analysis, there is the 0.10% return on equity and the 15.90% return on assets to consider. According to the past 12 months report, the income was almost $-3688.70M and sales remained $14.74B. Its price to sales ratio of 5.44 ranks higher than the industry’s 3.66. Its price/book multiple of 1.14 compared with the 4.54 while its free cash flow yield of 25.92 should be matched with that of its industry’s 8.96.

The Average True Range indicator applied to a daily chart of Apple has a current ATR reading of 3.25. This gives traders an indication of how much volatility or movement they can expect each day. Average True Range looks at the distance the price is traveling each day and plots it on a graph. The ATR reading can then be used by traders to determine when markets are most likely to range, when there is a high interest in a trend, or when extreme levels are being reached indicating a reversal.

Sunrun Inc. (NASDAQ:RUN) shares were last seen up 2.52% at $6.52, which is 59.91% higher than the previous trading session. The 52-week range is $4.15 to $7.34 and the consensus target price is $10.17. The company has a market cap of $661.19M and its 12 month revenue was almost $459.30M. The stock has been upbeat for quite some time as is up 33.06% for the last 20 trading days, and now the firm’s performance is turning out to be bullish with a 18.76% gain for the week. It has gain by over 4.65% in the last twelve months.

Going from the most bullish analyst price target to below consensus is one thing. Now Sunrun Inc. $10.17 target price is just $1.83 shy of the official lowest sell-side analyst price target on Wall Street. It looks like analysts are feeling bullish about the stock with overall sell-side analysts calling it a not a Buy. Their price objective ranges between $6.00 and $12.00.

For a profitability analysis, there is the 13.50% gross margin and the 19.90% net margin to consider. According to the past 5 years report, Its forward price to earnings ratio of 7.34 ranks lower than the industry’s 15.22. Its quick ratio was 1.20 while current ratio was noted as 1.40 in the most recent quarter.

The Sell-Side Reaction To Sunrun Inc. (RUN)’s Recent Shift

Sunrun Inc. (RUN) shares saw a recent bid of $6.36 and 3.84M shares have exchanged hands in the recent trading session, yielding a 16.06% gain over the past week. The stock price increased 8.72% or $-0.51 versus $5.85 at the end of the prior session. This change led market cap to move at $644.97M, putting the price -13.35% below the 52-week high and 53.25% above the 52-week low. The company’s stock has a normal trading capacity of 1.01M shares while the relative volume is 3.80.

To stay one step ahead we extended our research by comparing different price targets. The stock notched a 12-month high of $9.44 while $12.00 target is by far the most aggressive out of analysts who are currently evaluating the company, $2.56 higher than the next highest 52-week price estimate. The lowest 12-month price target for the shares is $6.00, which would be decrease of about -6% of its current value. The mean target of $9.50 should be compared with the price when the stock was languishing around $4.15 a share. And it remains to be seen which target price RUN can achieve without sacrificing much as the company is holding a 2.91% gain for the past twelve months.

By historical standards, Sunrun Inc. remains a cheap stock. The company’s current price-earnings ratio amounts to 6.75 times earnings, below the average P/E ratio of 15.39 times earnings. For now, Sunrun Inc. is the toast of Wall Street as its ABR stands at 2.00 with 3 out of 9 analysts rating the stock a buy. Over the short term, some market observers may have noticed that Sunrun Inc. has a 21.27% short float with 15 days to cover. It becomes significant when you consider how many shares are shorted versus the average daily volume, means how many days to cover those short shares at that volume. Sunrun Inc. has far performed well this year, with the share price up 19.77% since January. Over the past 2 quarters, the stock is up 13.77%, compared with a gain of nearly 32.50% for 3 months and about 25.94% for the past 30 days.

Last time, the company failed Wall Street by reporting EPS of $0.12, smashing the consensus of $0.14 per share. Revenue for the quarter also did not kill consensus, coming in at $104.12M, compared to the consensus of 119.35M. Nonetheless, from here on out, earnings per share forecasts for the current quarter are $0.35. The company is expected to report EPS as high as $0.74 and as low as $0.06 per share. Similarly, full-year EPS forecasts have ranged between $0.33 and $2.25. The mean EPS estimate is $1.17. On the other side, sales forecasts for the current quarter are $141.98M. The stock is expected to report revenue as high as $150.6M and as low as $132.2M per share. Similarly, full-year sales forecasts have ranged between $528M and $717.96M. The mean revenue estimate is $574.55M.

Over the last 5 years, Analysts are expecting EPS growth rates to be at 190.60% this quarter and EPS estimate for next year reflect 19.20% growth rate.

Sell-side analysts also have something to say about this company. UBS raised its rating on Sunrun Inc. to Buy on 22/03/2017 in a reversal from its prior Neutral rating. Barclays raised its rating on Sunrun Inc. to Overweight on 22/11/2016 in a reversal from its prior Equal Weight rating. JMP Securities had a markedly different take on 10/11/2016, proposing that Sunrun Inc. is now considered Mkt Perform versus prior Mkt Outperform rating. BofA/Merrill had a markedly different take on 09/11/2016, proposing that Sunrun Inc. is now considered Neutral versus prior Buy rating.

Time To Rake In Healthy Returns From Sunrun Inc. (RUN)

Sunrun Inc. (RUN) shares saw a recent bid of $5.74 and 1.49M shares have exchanged hands in the recent trading session, yielding a 6.10% gain over the past week. The stock price increased 3.99% or $-0.22 versus $5.52 at the end of the prior session. This change led market cap to move at $582.09M, putting the price -21.80% below the 52-week high and 38.31% above the 52-week low. The company’s stock has a normal trading capacity of 1.02M shares while the relative volume is 1.47.

To stay one step ahead we extended our research by comparing different price targets. The stock notched a 12-month high of $9.44 while $12.00 target is by far the most aggressive out of analysts who are currently evaluating the company, $2.56 higher than the next highest 52-week price estimate. The lowest 12-month price target for the shares is $6.00, which would be an increase of about 5% of its current value. The mean target of $9.50 should be compared with the price when the stock was languishing around $4.15 a share. And it remains to be seen which target price RUN can achieve without sacrificing much as the company is holding a -4.81% fall for the past twelve months.

By historical standards, Sunrun Inc. remains a cheap stock. The company’s current price-earnings ratio amounts to 6.63 times earnings, below the average P/E ratio of 15.26 times earnings. For now, Sunrun Inc. is the toast of Wall Street as its ABR stands at 2.00 with 3 out of 9 analysts rating the stock a buy. Over the short term, some market observers may have noticed that Sunrun Inc. has a 21.27% short float with 15 days to cover. It becomes significant when you consider how many shares are shorted versus the average daily volume, means how many days to cover those short shares at that volume. Sunrun Inc. has far performed well this year, with the share price up 8.10% since January. Over the past 2 quarters, the stock is up 9.54%, compared with a gain of nearly 15.96% for 3 months and about 19.33% for the past 30 days.

Last time, the company failed Wall Street by reporting EPS of $0.12, smashing the consensus of $0.14 per share. Revenue for the quarter also did not kill consensus, coming in at $104.12M, compared to the consensus of 119.35M. Nonetheless, from here on out, earnings per share forecasts for the current quarter are $0.35. The company is expected to report EPS as high as $0.74 and as low as $0.06 per share. Similarly, full-year EPS forecasts have ranged between $0.33 and $2.25. The mean EPS estimate is $1.17. On the other side, sales forecasts for the current quarter are $141.98M. The stock is expected to report revenue as high as $150.6M and as low as $132.2M per share. Similarly, full-year sales forecasts have ranged between $528M and $717.96M. The mean revenue estimate is $574.55M.

Over the last 5 years, Analysts are expecting EPS growth rates to be at 190.60% this quarter and EPS estimate for next year reflect 19.20% growth rate.

Sell-side analysts also have something to say about this company. UBS raised its rating on Sunrun Inc. to Buy on 22/03/2017 in a reversal from its prior Neutral rating. Barclays raised its rating on Sunrun Inc. to Overweight on 22/11/2016 in a reversal from its prior Equal Weight rating. JMP Securities had a markedly different take on 10/11/2016, proposing that Sunrun Inc. is now considered Mkt Perform versus prior Mkt Outperform rating. BofA/Merrill had a markedly different take on 09/11/2016, proposing that Sunrun Inc. is now considered Neutral versus prior Buy rating.

This Is Very Likely to Affect: Cloud Peak Energy Inc. (CLD), Sunrun Inc. (RUN)

Cloud Peak Energy Inc. (NYSE:CLD) was up 7.95% at $3.53 on Wednesday, in a 52-week range of $1.81 to $8.03 and with a consensus analyst target price of $4.83. As for the mean price target, it implies upside of 47.71% from the $3.27 prior closing price. Cloud Peak Energy Inc. has a 278.20M market cap and its past year revenues were 814.90M. Going from the most negative analyst price target to above consensus is one thing. Now Cloud Peak Energy Inc.’s current price is $3.47 shy of the official highest sell-side analyst price target on Wall Street.

Cloud Peak Energy Inc. (NYSE:CLD) has declined -37.08% since January and is up 5.37% for the past week. The share price of CLD has decreased by over -45.44% in the last six months. This increase is typical for the uptrend and shows the considerable optimism among investors.

A look at some of the inputs to technical analysis model shows how Cloud Peak Energy Inc. current price compares to its recent moving averages. Cloud Peak Energy Inc. is currently trading 3.13% above its 20-day and -28.35% versus the 200-day simple moving averages while -7.90% compared with its 50-day simple moving average. Additionally, Cloud Peak Energy Inc. (CLD) stock price has gone up by 4.13% over the last 20 trading days, and its price is -56.07% below the 52-week high.

For a total return analysis, there is the 4.90% return on equity and the 4.00% return on assets to consider. According to the past 12 months report, the income was almost $38.10M and sales remained $814.90M. Its price to sales ratio of 0.30 ranks lower than the industry’s 5.58. Its price/book multiple of 0.25 compared with the 1.89 while its free cash flow yield of 2.97 should be matched with that of its industry’s 8.49.

The Average True Range indicator applied to a daily chart of Apple has a current ATR reading of 0.18. This gives traders an indication of how much volatility or movement they can expect each day. Average True Range looks at the distance the price is traveling each day and plots it on a graph. The ATR reading can then be used by traders to determine when markets are most likely to range, when there is a high interest in a trend, or when extreme levels are being reached indicating a reversal.

Sunrun Inc. (NASDAQ:RUN) shares were last seen up 8.32% at $5.34, which is 98.78% higher than the previous trading session. The 52-week range is $4.15 to $7.34 and the consensus target price is $9.80. The company has a market cap of $564.12M and its 12 month revenue was almost $459.30M. The stock has been upbeat for quite some time as is up 8.98% for the last 20 trading days, and now the firm’s performance is turning out to be bullish with a 4.09% gain for the week. It has fall by over -18.10% in the last twelve months.

Going from the most bullish analyst price target to below consensus is one thing. Now Sunrun Inc. $9.80 target price is just $2.2 shy of the official lowest sell-side analyst price target on Wall Street. It looks like analysts are feeling bullish about the stock with overall sell-side analysts calling it a not a Buy. Their price objective ranges between $6.00 and $12.00.

For a profitability analysis, there is the 13.50% gross margin and the 19.90% net margin to consider. According to the past 5 years report, the company on average reported – year-over-year EPS growth and sales growth was recorded at -. Its forward price to earnings ratio of 5.69 ranks lower than the industry’s 15.51. Its quick ratio was 1.20 while current ratio was noted as 1.40 in the most recent quarter.

Sunrun Inc. (RUN) Traders Should Start Listening to Analysts

Sunrun Inc. (RUN) shares saw a recent bid of $4.93 and 983.94TH shares have exchanged hands in the recent trading session, yielding a -2.18% decline over the past week. The stock price decreased -1.79% or $0.09 versus $5.02 at the end of the prior session. This change led market cap to move at $520.81M, putting the price -32.83% below the 52-week high and 18.80% above the 52-week low. The company’s stock has a normal trading capacity of 1.10M shares while the relative volume is 0.90.

To stay one step ahead we extended our research by comparing different price targets. The stock notched a 12-month high of $9.11 while $12.00 target is by far the most aggressive out of analysts who are currently evaluating the company, $2.89 higher than the next highest 52-week price estimate. The lowest 12-month price target for the shares is $6.00, which would be an increase of about 22% of its current value. The mean target of $9.00 should be compared with the price when the stock was languishing around $4.15 a share. And it remains to be seen which target price RUN can achieve without sacrificing much as the company is holding a -23.33% fall for the past twelve months.

By historical standards, Sunrun Inc. remains a cheap stock. The company’s current price-earnings ratio amounts to 5.80 times earnings, below the average P/E ratio of 15.38 times earnings. For now, Sunrun Inc. is the toast of Wall Street as its ABR stands at 2.00 with 4 out of 11 analysts rating the stock a buy. Over the short term, some market observers may have noticed that Sunrun Inc. has a 18.40% short float with 15 days to cover. It becomes significant when you consider how many shares are shorted versus the average daily volume, means how many days to cover those short shares at that volume. Sunrun Inc. has far performed well this year, with the share price down -7.16% since January. Over the past 2 quarters, the stock is down -7.33%, compared with a fall of nearly -5.92% for 3 months and about 0.20% for the past 30 days.

Last time, the company failed Wall Street by reporting EPS of $0.12, smashing the consensus of $0.14 per share. Revenue for the quarter also did not kill consensus, coming in at $104.12M, compared to the consensus of 119.35M. Nonetheless, from here on out, earnings per share forecasts for the current quarter are $0.30. The company is expected to report EPS as high as $0.58 and as low as $0.06 per share. Similarly, full-year EPS forecasts have ranged between $0.33 and $1.93. The mean EPS estimate is $1.09. On the other side, sales forecasts for the current quarter are $145.47M. The stock is expected to report revenue as high as $174.9M and as low as $123.7M per share. Similarly, full-year sales forecasts have ranged between $528M and $640.88M. The mean revenue estimate is $562.72M.

Over the last 5 years, Analysts are expecting EPS growth rates to be at 190.60% this quarter and EPS estimate for next year reflect 30.44% growth rate.

Sell-side analysts also have something to say about this company. UBS raised its rating on Sunrun Inc. to Buy on 22/03/2017 in a reversal from its prior Neutral rating. Barclays raised its rating on Sunrun Inc. to Overweight on 22/11/2016 in a reversal from its prior Equal Weight rating. JMP Securities had a markedly different take on 10/11/2016, proposing that Sunrun Inc. is now considered Mkt Perform versus prior Mkt Outperform rating. BofA/Merrill had a markedly different take on 09/11/2016, proposing that Sunrun Inc. is now considered Neutral versus prior Buy rating.